Morse Asset Management, Inc Bristol Myers Squibb CO Transaction History

Morse Asset Management, Inc

$458 Million
Q3 2025

A detailed history of Morse Asset Management, Inc transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Morse Asset Management, Inc holds 5,800 shares of BMY stock, worth $271,498. This represents 0.06% of its overall portfolio holdings.

Number of Shares

5,800

Previous 5,800 -0.0%

Holding current value

$271,498

Previous $268,000 2.61%

% of portfolio

0.06%

Previous 0.06%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 15, 2025	SELL	$44.12 - $59.6 $570,030 - $770,032	-12,920 Reduced 69.02%	5,800 $268,000
Q1 2025 May 05, 2025	SELL	$53.9 - $63.11 $2.56 Million - $3 Million	-47,572 Reduced 71.76%	18,720 $1.14 Million
Q4 2024 Feb 14, 2025	BUY	$51.92 - $59.94 $2.92 Million - $3.37 Million	56,292 Added 562.92%	66,292 $3.75 Million
Q3 2024 Nov 14, 2024	BUY	$39.66 - $51.75 $79,320 - $103,500	2,000 Added 25.0%	10,000 $517,000
Q2 2023 Aug 14, 2023	SELL	$63.71 - $70.74 $63,710 - $70,740	-1,000 Reduced 11.11%	8,000 $512,000

Q1 2023 May 03, 2023	SELL	$65.71 - $74.53 $522,065 - $592,140	-7,945 Reduced 46.89%	9,000 $624,000
Q4 2022 Feb 08, 2023	SELL	$68.48 - $81.09 $6,848 - $8,109	-100 Reduced 0.59%	16,945 $1.22 Million
Q3 2022 Nov 14, 2022	SELL	$0.13 - $76.84 $2,148 - $1.27 Million	-16,525 Reduced 49.23%	17,045 $1.21 Million
Q2 2022 Aug 11, 2022	BUY	$72.62 - $79.98 $1.6 Million - $1.77 Million	22,070 Added 191.91%	33,570 $2.59 Million
Q4 2021 Feb 14, 2022	SELL	$53.63 - $62.52 $320,439 - $373,557	-5,975 Reduced 34.19%	11,500 $717,000
Q2 2021 Aug 13, 2021	SELL	$61.91 - $67.42 $30,955 - $33,710	-500 Reduced 2.78%	17,475 $1.17 Million
Q1 2021 May 13, 2021	SELL	$59.34 - $66.74 $745,310 - $838,254	-12,560 Reduced 41.13%	17,975 $1.14 Million
Q4 2020 Feb 11, 2021	SELL	$57.74 - $65.43 $4,907 - $5,561	-85 Reduced 0.28%	30,535 $1.89 Million
Q3 2020 Nov 09, 2020	BUY	$57.43 - $63.64 $132,089 - $146,372	2,300 Added 8.12%	30,620 $1.85 Million
Q2 2020 Aug 14, 2020	SELL	$54.82 - $64.09 $750,759 - $877,712	-13,695 Reduced 32.6%	28,320 $1.67 Million
Q1 2020 May 01, 2020	BUY	$46.4 - $67.43 $788,753 - $1.15 Million	16,999 Added 67.95%	42,015 $2.34 Million
Q4 2019 Jan 31, 2020	BUY	$49.21 - $64.19 $604,348 - $788,317	12,281 Added 96.44%	25,016 $1.61 Million
Q2 2019 Aug 01, 2019	SELL	$44.62 - $49.34 $5,131 - $5,674	-115 Reduced 0.89%	12,735 $578,000
Q1 2019 May 02, 2019	BUY	$45.12 - $53.8 $4,512 - $5,380	100 Added 0.78%	12,850 $613,000
Q3 2018 Nov 01, 2018	SELL	$55.19 - $62.25 $369,773 - $417,075	-6,700 Reduced 34.45%	12,750 $792,000
Q2 2018 Aug 15, 2018	SELL	$50.53 - $62.98 $176,855 - $220,430	-3,500 Reduced 15.25%	19,450 $1.08 Million
Q1 2018 May 02, 2018	BUY	$59.92 - $68.98 $722,036 - $831,209	12,050 Added 110.55%	22,950 $1.45 Million
Q4 2017 Jan 29, 2018	BUY	$59.94 - $65.35 $5,994 - $6,534	100 Added 0.93%	10,900 $668,000
Q3 2017 Oct 31, 2017	BUY	$55.23 - $63.74 $596,484 - $688,392	10,800	10,800 $688,000

Others Institutions Holding BMY

# of Institutions

2,717

Shares Held

1.58B

Call Options Held

28M

Put Options Held

28.4M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $99.5B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morse Asset Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Morse Asset Management, Inc with notifications on news.

Account

Morse Asset Management, Inc Bristol Myers Squibb CO Transaction History